Georgia Miebach

University Hospital Heidelberg

Papers

2

Total Citations

24

H-Index

2

About

Georgia Miebach is a radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for liver metastases, with a particular emphasis on active motion-compensation techniques. Her major contributions include demonstrating that liver SBRT with active motion management achieves excellent local control rates for oligometastatic disease, as shown in her most-cited work (21 citations), a pooled multi-platform cohort analysis. She has also pioneered the long-term characterization of MRI-morphological changes in hepatic tissue following motion-compensated SBRT, providing critical insights into normal tissue toxicity and treatment planning for multimodal regimes. This work, though recently published (3 citations), addresses a vital gap in understanding late radiation effects. Miebach’s research is notable for its multi-institutional, pooled analysis approach, which strengthens the generalizability of her findings. Her achievements are particularly relevant for clinicians and researchers navigating the intersection of advanced radiotherapy delivery and imaging-based toxicity assessment, positioning her as a key contributor to optimizing SBRT for liver malignancies.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University Hospital Heidelberg

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago